KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ASND
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ascendis Pharma A/S stock price ended at $135.90 on Friday, after losing 0.752%.
(Updated on Apr 26, 2024)

Sell candidate since Apr 25, 2024 Loss -0.75% PDF

The Ascendis Pharma A/S stock price fell by -0.752% on the last day (Friday, 26th Apr 2024) from $136.93 to $135.90. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 4.81% from a day low at $133.39 to a day high of $139.81. The price has fallen in 7 of the last 10 days and is down by -6.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -139 thousand shares and in total, 225 thousand shares were bought and sold for approximately $30.61 million.

The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $130.60 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Ascendis Pharma A/S stock with a 90% probability to be traded between $131.76 and $161.84 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ASND Signals & Forecast

There are few to no technical positive signals at the moment. The Ascendis Pharma A/S stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $140.57 and $146.67. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 23, 2024, and so far it has fallen -14.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Ascendis Pharma A/S stock

Ascendis Pharma A/S finds support from accumulated volume at $134.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $6.42 between high and low, or 4.81%. For the last week, the stock has had daily average volatility of 3.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ASND) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Ascendis Pharma A/S to open at $136.37, and during the day (based on 14 day Average True Range), to move between $130.69 and $141.11, which gives a possible trading interval of +/-$5.21 (+/-3.83%) up or down from last closing price. If Ascendis Pharma A/S takes out the full calculated possible swing range there will be an estimated 7.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $134.39 (1.11%) than the resistance at $139.29 (2.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ascendis Pharma A/S stock A Buy?

Ascendis Pharma A/S holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.999 Sell Candidate Unchanged

Predicted Opening Price for Ascendis Pharma A/S of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$136.37 ( 0.342%) $135.90

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ASND

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 142.78 5.06 %
R2 140.33 3.26 %
R1 138.82 2.15 %
Current price: 135.90
Support S1 133.91 -1.46 %
S2 132.40 -2.58 %
S3 129.95 -4.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 145.37 6.97 %
R2 143.35 5.48 %
R1 139.29 2.49 %
Current price 135.90
Support S1 134.39 -1.11%
S2 129.93 -4.39%
S3 129.20 -4.93%

FAQ

What is the symbol for Ascendis Pharma A/S Stock and on which exchange is it traded?
The symbol for Ascendis Pharma A/S is ASND and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ascendis Pharma A/S Stock?
Ascendis Pharma A/S holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Ascendis Pharma A/S Stock?
Ascendis Pharma A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ascendis Pharma A/S Stock.

What's the current price of Ascendis Pharma A/S Stock?
As of the end of day on the Apr 26, 2024, the price of an Ascendis Pharma A/S (ASND) share was $135.90.

What is the 52-week high and low for Ascendis Pharma A/S Stock?
The 52-week high for Ascendis Pharma A/S Stock is $161.00 and the 52-week low is $66.03.

What is the market capitalization of Ascendis Pharma A/S Stock?
As of the Apr 26, 2024, the market capitalization of Ascendis Pharma A/S is 7.752B.

When is the next earnings date for Ascendis Pharma A/S?
The upcoming earnings date for Ascendis Pharma A/S is Sep 03, 2024.
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT